AI주식인사이트AI Stock Insight
C

셀바스헬스케어

208370KOSDAQ의료용 기기 제조업

47.5 / 100

Reference Date: 2026-06-10

Financial Score21.0 / 40
News Sentiment12.5 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Plunged 25.2% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Selbas Healthcare is a digital health specialist company with two business units: medical diagnostic devices 'ACCUNIQ' and assistive technology for visually impaired individuals 'HIMS'. ACCUNIQ's flagship product, the body composition analyzer 'BC380', boasts 98% accuracy, while HIMS's BrailleSense Polaris utilizes Google Mobile Services certification with advanced IT technology. The company is expanding its global market through subsidiaries in the U.S. and China, as well as an established international distribution network.

Number of Employees

139people

Average Salary

49.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
20.46Industry Average 21.515.0Point

In line with industry avg

PBR
1.12Industry Average 1.384.0Point

In line with industry avg

ROE
5.77Industry Average 8.002.5Point

Below industry avg

Debt Ratio
4.02Industry Average 11.656.5Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲1.8% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼53.5% (2-year basis)

ROE Trend
2.0 / 4

Avg ROE 7.3% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 3,090Won52-week high 6,65052-week low 3,090
1-month return0.0Point

1m -25.18% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral[기재정정]사업보고서 (2025.12)2026-05-15
  • Neutral분기보고서 (2026.03)2026-05-15